Addressing the HIV epidemic in Eastern Europe and Central AsiaWorking in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. 2021 Share XAddressing the HIV epidemic in Eastern Europe and Central Asiahttps://pharmaphorum.com/patients/gilead-hiv-epidemic-eastern-europe-central-asia/
It’s time to do better for patients with rare neurological disordersGlobal Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to Share XIt’s time to do better for patients with rare neurological disordershttps://pharmaphorum.com/patients/global-genes-rare-neurological-disorder-research/
The post-COVID future of physician sample access and engagementBuilding modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says Share XThe post-COVID future of physician sample access and engagementhttps://pharmaphorum.com/sales-marketing/covid-physician-pharma-access-engagement/
Taking stock of NHS medicines optimisationGiven the rising cost of medicines as a share of the NHS budget in England, the establishment of Share XTaking stock of NHS medicines optimisationhttps://pharmaphorum.com/patients/nhs-confederation-medicines-optimisation-ics/
EFPIA: Partnership is the key to healthcare’s biggest challengesThe European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning Share XEFPIA: Partnership is the key to healthcare’s biggest challengeshttps://pharmaphorum.com/sales-marketing/efpia-pharma-healthcare-partnership-guide/
The tech revolution reshaping European healthcareThe European health tech industry has made a “quantum leap” into using digital health technology due to the Share XThe tech revolution reshaping European healthcarehttps://pharmaphorum.com/digital/health-tech-revolution-reshaping-europe/
France’s biotech ecosystem is primed for growth – it’s time to feed itAfter some years of stagnant funding and growth France is now at an inflection point for health care Share XFrance’s biotech ecosystem is primed for growth – it’s time to feed ithttps://pharmaphorum.com/r-d/france-biotech-ecosystem-jeito-capital/
Disparities between CEE and EU5 healthcare systems laid bareIncreasing public spending on healthcare in Central and Eastern Europe (CEE) could not only result in healthier populations, Share XDisparities between CEE and EU5 healthcare systems laid barehttps://pharmaphorum.com/sales-marketing/central-eastern-europe-eu5-health-disparities/
Preparing for a post-pandemic worldJanssen’s Mark Hicken, VP of strategy, EMEA, looks at what COVID-19 has taught us and how we can Share XPreparing for a post-pandemic worldhttps://pharmaphorum.com/sales-marketing/janssen-mark-hicken-pharma-post-pandemic/
